Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line

被引:127
|
作者
Ramachandran, C
Fonseca, HB
Jhabvala, P
Escalon, EA
Melnick, SJ
机构
[1] Miami Childrens Hosp, Dept Pathol, Miami, FL 33155 USA
[2] Miami Childrens Hosp, Res Inst, Miami, FL 33155 USA
[3] Miami Childrens Hosp, Div Hematol & Oncol, Miami, FL 33155 USA
关键词
curcumin; telomerase; human telomerase reverse transcriptase; telomerase RNA; c-myc; real-time reverse transcription-polymerase chain reaction;
D O I
10.1016/S0304-3835(02)00192-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The inhibitory effect of curcumin, the yellow-colored pigment from turmeric, on telomerase activity was analyzed in human mammary epithelial (MCF-10A) and breast cancer (MCF-7) cells. Telomerase activity in MCF-7 cells is 6.9-fold higher than that of human mammary epithelial cells. In MCF-7 cells, telomerase activity decreased with increasing concentrations of curcumin, inhibiting about 93.4% activity at 100 muM concentration. The inhibition of telomerase activity in MCF-7 cells may be due to down-regulation of hTERT expression. Increasing concentrations of curcumin caused a steady decrease in the level of hTERT mRNA in MCF-7 cells whereas the level of hTER and c-myc mRNAs remained the same. Our results suggest that curcumin inhibits telomerase activity by down-regulating hTERT expression in breast cancer cells and this down-regulation is not through the c-myc pathway. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [21] Targeting growth of breast cancer cell line (MCF-7) with curcumin-pyrimidine analogs
    Siraj B Shaikh
    Pranav Tambe
    Yusufi Mujahid
    Manas K Santra
    Bernhard Biersack
    Khursheed Ahmed
    Journal of Chemical Sciences, 134
  • [22] Targeting growth of breast cancer cell line (MCF-7) with curcumin-pyrimidine analogs
    Shaikh, Siraj B.
    Tambe, Pranav
    Mujahid, Yusufi
    Santra, Manas K.
    Biersack, Bernhard
    Ahmed, Khursheed
    JOURNAL OF CHEMICAL SCIENCES, 2022, 134 (04)
  • [23] Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib
    Chen, Chen
    Shen, Hui Ling
    Yang, Jing
    Chen, Qiao Yun
    Xu, Wen Lin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (01) : 9 - 17
  • [24] HETEROGENEITY OF THE HUMAN-BREAST CANCER CELL-LINE MCF-7
    BUTLER, B
    BERLINSKI, PJ
    KELSEY, WH
    TOENNIGES, MM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 236 - 236
  • [25] Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway
    Huq, A. K. M. Moyeenul
    Wai, Lam Kok
    Rullah, Kamal
    Aluwi, Mohd Fadhlizil Fasihi Mohd
    Stanslas, Johnson
    Jamal, Jamia Azdina
    CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (03) : 222 - 231
  • [26] Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib
    Chen Chen
    Hui Ling Shen
    Jing Yang
    Qiao Yun Chen
    Wen Lin Xu
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 9 - 17
  • [27] Vitamin D - Metabolism in the human breast cancer cell line MCF-7
    Diesing, Dagmar
    Cordes, Tim
    Fischer, Dorothea
    Diedrich, Klaus
    Friedrich, Michael
    ANTICANCER RESEARCH, 2006, 26 (4A) : 2755 - 2759
  • [28] Telomerase activity and cell apoptosis in colon cancer cell by human telomerase reverse transcriptase gene antisense oligodeoxynucleotide
    Jiang, YA
    Luo, HS
    Zhang, YY
    Fan, LF
    Jiang, CQ
    Chen, WJ
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (09) : 1981 - 1984
  • [29] Telomerase activity and cell apoptosis in colon cancer cell by human telomerase reverse transcriptase gene antisense oligodeoxynucleotide
    Ying-An Jiang He-Sheng Luo Department of Gastroenterology
    World Journal of Gastroenterology, 2003, 9 (09) : 1981 - 1984
  • [30] Lipotrope deficiency inhibits cell growth and induces programmed cell death in human breast cancer cell line MCF-7
    Wu, D
    Keller, WL
    Park, CS
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1998, 32 (01): : 13 - 19